Abbott Reports 7 Deaths Linked to Glucose Sensor Problem
Abbott advises users to stop using about 3 million affected sensors after false low glucose readings caused over 700 severe adverse events worldwide, including 57 in the U.S.
8 Articles
8 Articles
Abbott Reports 7 Deaths Linked to Glucose Sensor Problem
(MedPage Today) -- Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may provide false low glucose readings. Hundreds of adverse events and seven deaths worldwide have been...
Abbott Laboratories Issues Correction on 3 Million Glucose Sensors Over Possible Faulty Readings
Global health care company Abbott Laboratories has initiated a medical device correction on nearly 3 million glucose-monitoring sensors following internal testing that indicated some sensors may provide incorrect low glucose readings. The device corrections include the FreeStyle Libre 3 and FreeStyle Libre 3 Plus models in the United States. The FreeStyle Libre 3 system is a continuous glucose-monitoring (CGM) system that includes the sensor and…
Abbott issues correction over incorrect FreeStyle Libre sensor readings
Abbott has initiated a medical device correction for sensors used in certain FreeStyle Libre 3 continuous glucose monitoring (CGM) systems in the US after determining that some of them may be providing incorrect low glucose readings.The post Abbott issues correction over incorrect FreeStyle Libre sensor readings appeared first on Medical Device Network.
The South Karelia Welfare Region and the sensor manufacturer are trying to reach patients.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium



